Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03792451 · ClinicalTrials.gov registry record
Nutrition Status of Adults Treated With Pegvaliase
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 18
- Enrollment target
NCT03792451 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 18 participants.
The verdict
NCT03792451 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Conduct a cross-sectional analysis of the nutritional status of individuals with PKU treated with pegvaliase for one or more years or who have followed an unrestricted diet for 6 or more months while on pegvaliase treatment. We will evaluate laboratory markers of nutritional status, including markers of protein and micronutrient nutriture. In addition, a three-day food record and food frequency questionnaire will be obtained to assess protein intake and overall diet quality.
Interventions
- DRUG Pegvaliase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-01-17 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03792451
The ClinicalTrials.gov registry entry for NCT03792451 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pegvaliase is the first listed.
NCT03792451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03792451 about?
NCT03792451 is a clinical study titled "Nutrition Status of Adults Treated With Pegvaliase". Conduct a cross-sectional analysis of the nutritional status of individuals with PKU treated with pegvaliase for one or more years or who have followed an unrestricted diet for 6 or more months while on pegvaliase treatment. We will evaluate laboratory markers of nutritional status, including marker...
What is the current status of trial NCT03792451?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2019-01-17. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03792451?
The interventions under investigation include: Pegvaliase (DRUG).
Who is sponsoring clinical trial NCT03792451?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.